POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies

Autor: Alten, R, Burmester, G, Matucci-Cerinic, M, Salmon, JH, Zaremba-Pechmann, L, Fakhouri, W, de La Torre, I, Herrera, M, Holzkämper, T, Fautrel, B
Zdroj: In Value in Health January 2022 25(1) Supplement:S221-S221
Databáze: ScienceDirect
Externí odkaz: